Trump's Tariff Tangle: A Recipe for Higher Prices and Indian Worries The pharmaceutical industry is a massive global trade network that spans billions of dollars in transactions between nations.
US President Donald Trump has inserted his own thread into this complex web, proposing a 200% tariff plan on generic medicines imported from countries like India.
While touted as a boon for domestic manufacturing, the reality is far more nuanced. Dr Reddy's Laboratories, an Indian pharmaceutical giant, has sounded the alarm about the impending tariffs.